3Kedziora KK, Czuczejko J , Pawluk H, et al. The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension. Cell Mol Biol Lett, 2004; 9(4A): 635 -641.
4Oscar A P, Melissa B B and Julio A P. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation, 2001 ; 103(13): 1752 -1758.
5Vender RI. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. Chest, 1994; 106(12): 236 - 243.
6OSAMAH H,MIRA R,SORINA S,et al.Reduced platelet aggregation after fluvastatin therapy is associated with atered platelet lipid composition and drug binding to the platelets[J].Br J Clin Pharmacol,1997,44(1):77-83.
7O'DRISCOLL G,GREEN D,TAYLOR R R.Simvastatin,an HMG-co-enzyme A reductase inhibitor,improves endothelial function within 1 months[J].Circulation,1997,95(5):1 126-1 131.
8RIDKER P M,RIFAI N,PFEFFER M A,et al.Long-term effects of pravastatin on plasma concentration of C-reactive protein.The cholesterol and recurrent events (CARE) investigators[J].Circulation,1999,100(3):230-235.
9KEDZIORA K K,CZUCZEJKO J,PAWLUK H,et al.The markers of oxidative stress and activity of the antioxidant system in the blood of elderly patients with essential arterial hypertension[J].Cell Mol Biol Lett,2004,9(4A):635-641.
10LAUFS U,FATA V L,PLUTZKY J,et al.Upregulation of endothehal nitric oxide synthase by HMG-CoA reductase inhibitors[J].Circulation,1998,97(12):1 129-1 135.
